Open-Label trial on the effects of memantine in adults with obsessive-compulsive disorder after a single ketamine infusion

J Clin Psychiatry. 2016 May;77(5):688-9. doi: 10.4088/JCP.15l10318.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Intravenous
  • Adult
  • Diagnostic and Statistical Manual of Mental Disorders
  • Drug Substitution / methods
  • Excitatory Amino Acid Antagonists / administration & dosage
  • Excitatory Amino Acid Antagonists / adverse effects
  • Female
  • Humans
  • Ketamine* / administration & dosage
  • Ketamine* / adverse effects
  • Male
  • Memantine* / administration & dosage
  • Memantine* / adverse effects
  • Middle Aged
  • Obsessive-Compulsive Disorder* / diagnosis
  • Obsessive-Compulsive Disorder* / drug therapy
  • Pilot Projects
  • Psychiatric Status Rating Scales
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors*
  • Treatment Outcome

Substances

  • Excitatory Amino Acid Antagonists
  • Receptors, N-Methyl-D-Aspartate
  • Ketamine
  • Memantine

Associated data

  • ClinicalTrials.gov/NCT00956085